These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8857137)

  • 21. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
    Jee SR; Seol SY; Kim DH; Park SJ; Han SY; Urm SH; Lee JT
    Korean J Gastroenterol; 2005 May; 45(5):321-7. PubMed ID: 15908764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era.
    Nayyar AK; Royston C; Bardhan KD
    Dig Liver Dis; 2003 Mar; 35(3):143-50. PubMed ID: 12779067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.
    Marks RD; Richter JE; Rizzo J; Koehler RE; Spenney JG; Mills TP; Champion G
    Gastroenterology; 1994 Apr; 106(4):907-15. PubMed ID: 7848395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
    Jeong HY; Lee BS; Sung JK; Lee TY; Yoon SJ; Kim SJ; Chung IK; Lee SH; Shin JE; Lee DS; Baek JT; Nam SW; Yoon SJ; Kim SH; Lee GS; Lee JM; Kim AN; Oh JI
    Korean J Gastroenterol; 2006 Jan; 47(1):15-21. PubMed ID: 16434864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
    Sandmark S; Carlsson R; Fausa O; Lundell L
    Scand J Gastroenterol; 1988 Jun; 23(5):625-32. PubMed ID: 3041558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
    Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
    Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptic esophageal stricture: is surgery still necessary?
    Bischof G; Feil W; Riegler M; Wenzl E; Schiessel R
    Wien Klin Wochenschr; 1996; 108(9):267-71. PubMed ID: 8686319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures.
    Ramage JI; Rumalla A; Baron TH; Pochron NL; Zinsmeister AR; Murray JA; Norton ID; Diehl N; Romero Y
    Am J Gastroenterol; 2005 Nov; 100(11):2419-25. PubMed ID: 16279894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
    Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.
    Vantrappen G; Rutgeerts L; Schurmans P; Coenegrachts JL
    Dig Dis Sci; 1988 May; 33(5):523-9. PubMed ID: 3282846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
    Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
    Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
    Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
    Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.
    Blum AL; Riecken EO; Dammann HG; Schiessel R; Lux G; Wienbeck M; Rehner M; Witzel L
    N Engl J Med; 1986 Mar; 314(11):716. PubMed ID: 3513011
    [No Abstract]   [Full Text] [Related]  

  • 37. Surgical management of severe peptic esophageal stricture in children.
    al-Bassam A
    Hepatogastroenterology; 2003; 50(51):714-7. PubMed ID: 12828068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.